ACTIVE SUBSTANCE / INN

SILDENAFIL CITRATE

Brand name(s): REVATIO, LIQREV, VYBRIQUE, VIAGRA, SILDENAFIL CITRATE
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
ANDA201150
NDA210858
ACTIVE SUBSTANCE
Sildenafil Citrate
REGULATORS
FDA
SPONSORS / MAH
VIATRIS, ACTAVIS PHARMA, IBSA
TOTAL APPLICATIONS
7
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
SILDENAFIL CITRATEANDA200165ACTAVIS PHARMANone (Tentative Approval)
SILDENAFIL CITRATEANDA201150MYLAN PHARMS INCDiscontinued
SILDENAFIL CITRATEANDA202023AMNEAL PHARMS NYPrescription
LIQREVNDA214952CMP DEV LLCDiscontinued
REVATIONDA203109VIATRISPrescription
VYBRIQUENDA210858IBSAPrescription
VIAGRANDA020895VIATRISPrescription

FULL INTELLIGENCE ON SILDENAFIL CITRATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →